Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Biocryst
Biocryst
BioCryst nixes merger, sending Idera stock down
Biopharma Dive
Thu, 07/12/18 - 06:19 pm
Idera
Biocryst
M&A
BioCryst Urges Stockholders To Vote For Merger With Idera
CP Wire
Tue, 06/5/18 - 11:58 am
Biocryst
M&A
Idera
BioCryst Urges Stockholders To Vote For Merger With Idera
Tue, 06/5/18 - 09:51 am
Biocryst
Idera Pharmaceuticals
Idera, Biocryst to merge, rebrand and focus in rare disease programs
Endpoints
Mon, 01/22/18 - 10:56 am
Idera
Biocryst
M&A
Rare Diseases
These 5 Biotech Stocks Under $10 Are About to Break Out
TheStreet.com
Fri, 04/1/16 - 09:23 am
biotech
Ardelyx
Biocryst
Affimed
Adaptimmune
Sangamo BioSciences
Biotech's Top 5 Stock Winners, And Losers, In Q1 2016
Forbes
Thu, 03/31/16 - 09:49 pm
biotech
PTC Therapeutics
Celldex Therapeutics
Biocryst
Puma Biotechnology
Portola Pharmaceuticals
MedicNova
BioTie Therapies
Editas Medicine
AveXis
Inovio
8 Major Biopharma Events Coming Later in 2016 and in 2017
24/7 Wall St
Tue, 03/29/16 - 10:33 pm
Vertex Pharmaceuticals
VX-661
cystic fibrosis
Incyte
ruxolitinib
colorectal cancer
breast cancer
Ultragenyx
KRN23
osteomalacia
GW Pharma
Epidiolex
Puma Biotechnology
neratinib
Celator Pharmaceuticals
Vyxeos
Biocryst
OPuS-2
BCX7353
HAE
Galena Biopharma
NeuVax
trastuzumab
BioCryst's Zika drug shows promise in mice
Yahoo/Reuters
Mon, 03/7/16 - 09:35 am
Biocryst
Zika virus
BCX443
4 BioPharma Movers That Cannot Be Ignored
24/7 Wall St
Tue, 02/16/16 - 09:58 am
CTI BioPharma
Incyte
Biocryst
NxStage Medical
4 Key FDA Decisions Expected By Year End
24/7 Wall St
Sun, 11/29/15 - 12:43 pm
FDA
Achillion
hepatitis C
Biocryst
OPuS-2
BCX4161
Tetraphase Pharmaceuticals
Lucitanib
Clovis Oncology
4 Key FDA Decisions Expected in November and December
24/7 Wall St
Sun, 11/1/15 - 11:18 am
FDA
Androxal
Repros Therapeutics
elvitegravir
cobicistat
emtricitabine
tenofovir alafenamide
OPuS-2
Biocryst
Synergy Pharmaceuticals
plecanatide
We Believe Healthcare's Next Biotech Buyout Target Is…
Motley Fool
Sun, 08/30/15 - 02:05 pm
M&A
Biocryst
Biogen
Exelixis
2 Biotech Stocks That Could Skyrocket In The Next 12 Months
Yahoo/Benzinga
Tue, 08/11/15 - 09:49 am
biotech
Biocryst
Threshold Pharmaceuticals
5 Big Biotechs Not Keeping Up at All With Hot Biotech Sector in 2015
24/7 Wall St
Sat, 04/18/15 - 12:16 pm
Cerus
Nektar
Idera Pharmaceuticals
BioDelivery Sciences
Biocryst
BioCryst Pharma wins federal contract to continue making Ebola drug
Yahoo/Reuters
Tue, 03/31/15 - 07:59 am
Biocryst
ebola virus
Special FDA designation puts more wind behind BioCryst's sails
Bizjournals.com
Mon, 01/26/15 - 10:01 am
FDA
Biocryst
BCX4161
hereditary angiodema
BioCryst Hits Trifecta For Flu, Ebola, and Hereditary Angioedema
Forbes
Fri, 12/26/14 - 10:22 pm
Biocryst
Flu
ebola virus
hereditary angiodema
Rapivab
BCX4430
BCX4161
FDA approves BioCryst's intravenous flu drug
Yahoo/Reuters
Mon, 12/22/14 - 09:28 am
FDA
Flu
Biocryst
Rapivab
peramivir
The FDA May Find Some Use For Rapivab And Approve The Influenza Antiviral
Seeking Alpha
Thu, 12/18/14 - 04:09 pm
FDA
Rapivab
Biocryst
Flu
antivirals
5 Critical Biotech Drug Dates and Events for December
24/7 Wall St
Mon, 12/1/14 - 04:45 pm
biotech
Incyte
ruxolitinib
Cubist Pharma
ceftolozane/tazobactam
Biocryst
peramivir
Vertex Pharmaceuticals
Kalydeco
Pozen
PA8140/PA32540
Pages
« first
‹ previous
1
2
3
4
5
6
next ›
last »